GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Veracyte VCYT · USD

Health Care · US listing · 🇺🇸 United States

Compare

25.92

+7.28%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$517.1m

FY2016FY2025

Net income

$66.4m

FY2016FY2025

Free cash flow

$126.6m

FY2016FY2025

Shareholders' equity

$1.31bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$517.1m$445.8m$361.1m$296.5m$219.5m$117.5m$120.4m$92.0m$72.0m$65.1m
Gross profit$360.0m$298.1m$248.1m$195.0m$145.1m$76.0m$83.8m$58.9m$43.8m$39.6m
Research and development$70.8m$69.3m$57.3m$40.6m$29.8m$17.2m$14.9m$14.8m$13.9m$15.3m
Operating income$74.2m$16.1m−$85.8m−$41.1m−$81.9m−$35.4m−$15.1m−$21.0m−$27.6m−$28.6m
Net income$66.4m$24.1m−$74.4m−$36.6m−$75.6m−$34.9m−$12.6m−$23.0m−$31.0m−$31.4m
Diluted earnings per share0.820.30-1.02-0.51-1.06-0.60-0.26-0.56-0.91-0.99

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.41bn$1.30bn$1.11bn$1.16bn$1.19bn$457.2m$275.2m$120.6m$78.7m$101.0m
Cash and short-term investments$412.9m$289.4m$216.5m$178.9m$177.2m$349.4m$159.3m$78.0m$33.9m$59.2m
Total liabilities$96.4m$124.1m$70.8m$81.2m$91.3m$35.9m$35.8m$40.9m$41.4m$41.5m
Debt——$100,000$400,000$1.7m$800,000$700,000$25.3m$25.2m$25.5m
Shareholders' equity$1.31bn$1.18bn$1.04bn$1.08bn$1.10bn$421.2m$239.5m$79.8m$37.2m$59.6m
Shares outstanding81m80m73m72m71m58m49m41m34m32m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$136.3m$75.1m$44.2m$7.5m−$31.6m−$9.7m−$3.2m−$13.5m−$23.9m−$28.0m
Capital spending−$9.7m−$11.3m−$10.0m−$8.5m−$5.4m−$2.8m−$2.8m−$1.9m−$1.8m−$4.2m
Free cash flow$126.6m$63.8m$34.3m−$1.0m−$37.0m−$12.5m−$6.0m−$15.4m−$25.7m−$32.2m
Dividends paid———−$3.2m—−$3.8m−$977,000———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$150.3m$139.1m$140.6m$131.9m$130.2m$114.5m$118.6m$115.9m
Gross profit$108.6m$100.6m$104.7m$91.3m$89.8m$79.5m$78.8m$79.0m
Operating income$23.0m$23.8m$25.9m$22.9m−$5.3m$2.9m$4.2m$12.0m
Net income$25.5m$28.7m$41.1m$19.1m−$980,000$7.0m$5.1m$15.2m
Diluted earnings per share0.310.350.510.24-0.010.090.060.19
Cash from operations$45.0m$35.0m$52.0m$44.0m$33.0m$5.0m$24.0m$29.0m
Capital spending−$2.0m−$2.0m−$4.0m−$2.0m−$1.0m−$1.0m−$4.0m−$2.0m
Free cash flow$43.0m$33.0m$48.0m$42.0m$32.0m$4.0m$20.0m$27.0m
Total assets$1.49bn$1.44bn$1.41bn$1.37bn$1.34bn$1.32bn$1.30bn$1.28bn
Cash and short-term investments$485.2m$439.1m$412.9m$366.4m$320.7m$287.4m$289.4m$274.1m
Debt$5.8m$4.3m$4.1m$4.3m$6.4m$7.4m$7.5m$7.3m
Shareholders' equity$1.39bn$1.34bn$1.31bn$1.26bn$1.22bn$1.19bn$1.18bn$1.18bn

Financial ratios

Data as of 26 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin69.6%66.9%68.7%65.7%66.1%64.7%
Operating margin13.2%5.8%-21.2%-12.2%-37.1%-29.5%
Net margin12.8%5.4%-20.6%-12.3%-34.4%-29.7%
Return on equity5.1%2.1%-7.1%-3.4%-6.9%-8.3%
Return on assets4.7%1.9%-6.7%-3.2%-6.4%-7.6%
Free cash flow yield3.7%2.3%1.5%0.5%-0.8%-0.2%
Revenue growth16.0%23.5%21.8%35.1%86.8%-2.4%
Earnings growth174.9%-132.4%103.5%-51.6%116.5%177.1%
Current ratio8.15x4.73x4.66x3.97x3.79x22.39x
Debt to equity0.00x0.01x0.00x0.00x0.00x0.01x
Equity ratio93.1%90.5%93.6%93.0%92.3%92.1%
Interest coverage68201.00x12873.00x-5106.47x-182.97x-337.79x-151.44x
R&D as a share of sales13.7%15.5%15.9%13.7%13.6%14.6%
Buybacks as a share of market value-1.9%-9.3%-1.8%-1.1%-22.5%-18.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.4%34.5%26.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin68.4%68.0%67.6%66.9%
Operating margin9.4%-2.3%-7.9%-11.9%
Net margin9.4%-1.3%-6.7%-11.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings51.6131.1-27.0-46.6-38.8-81.3-108.8-22.3-7.2-7.8
Price to sales6.67.15.65.813.324.211.45.63.13.8

Market value over time

30 Nov 2016 to 23 Oct 2026, in USD

$213.6m$3.94bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return6%38%9%-36%-20%80%146%73%-9%9%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.